US insurance claims show strong link between erectile dysfunction medications and vision problems

Credit: CC0 Public Domain

The risk of developing one of three serious eye conditions increases by 85 percent for regular users of common erectile dysfunction (ED) medications such as Viagra, Cialis, Levitra and Stendra, new UBC research has found.

Two of the three conditions had previously been linked to ED medications only by anecdotal case studies. Those links are now confirmed for the first time by a large, , published today in JAMA Ophthalmology.

"These are rare conditions, and the risk of developing one remains very low for any individual user. However, the sheer number of prescriptions dispensed each month in the U.S.—about 20 million—means that a significant number of people could be impacted," said Dr. Mahyar Etminan (he/him), an associate professor in the department of ophthalmology and visual sciences at the UBC faculty of medicine. "Regular users of these drugs who find any changes in their vision should take it seriously and seek ."

Following insurance claims

The researchers analyzed health insurance claim records of 213,000 men in the U.S. who had not experienced any of these eye problems in the year before they became regular users of ED medications.

They followed the records to see how many men developed one or more of the three conditions, and how that rate compared to men who didn't use the medications. After accounting statistically for other conditions such as hypertension, diabetes and that are known to be associated with , they found the increased risk for each to be as follows:

U.S. insurance claims show strong link between ED medications and vision problems

A possible explanation

The study showed only the statistical association between eye conditions and use of Viagra, Cialis, Levitra or Stendra. It did not prove that the drugs cause these conditions.

However, ED medications function in a way that suggests some possible explanations.

"These medications address by improving blood flow, but we know that they can also hinder in other parts of the body," said Dr. Etminan. "So although our study doesn't prove cause-and-effect, there is a mechanism by which these medications could conceivably lead to these problems. The totality of the evidence points toward a strong link."

Warnings needed

The potential risk of SRD and RVO is not addressed in the information currently provided to patients along with their ED medications, unlike the ION risk which has been demonstrated by previous research.

Dr. Etminan hopes his team's work will change that. Patients who are unaware of all potential side effects might not seek help in time to avoid serious visual consequences.

More information: Risk of Ocular Adverse Events Associated With Use of Phosphodiesterase-5 Inhibitors in Men in the US, JAMA Ophthalmology (2022). DOI: 10.1001/jamaophthalmol.2022.0663

Journal information: JAMA Ophthalmology
Citation: US insurance claims show strong link between erectile dysfunction medications and vision problems (2022, April 7) retrieved 21 February 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Do hormonal contraceptives impact glaucoma risk?


Feedback to editors